ALGS
#4515
Aligos Therapeutics, Inc. - Common stock
6.9 1 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.26%
Monthly Change
+67.31%
6 month change
+0.44%
Year Change
-29.42%
Previous Close
7.0 7
Open
6.9 1
Low
6.9 1
High
6.9 1
Volume
3
Financials
- Market Capitalization 23.94 M
- Employee 82
- Founded 2018
- CEO N/A
- Website www.aligos.com
- Headquarter Delaware, United States
- FIGI BBG00QX7QH68
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.8
Price to sales ratio
21
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4512 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.82 USD | +0.55% | -2.67% | -14.15% | -49.44% | 24.28 M USD | ||
| 4514 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 1.03 USD | +4.04% | -14.17% | -26.95% | -72.68% | 24.14 M USD | ||
| 4516 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.53 USD | -0.39% | -1.56% | -3.07% | -19.43% | 23.91 M USD | ||
| 4522 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.70 USD | 0.00% | 0.00% | +16.67% | -74.73% | 23.29 M USD |
Frequently asked questions about Aligos Therapeutics, Inc. Common Stock
What is the Aligos Therapeutics, Inc. Common Stock stock price today?
The current price of Aligos Therapeutics, Inc. Common Stock (ALGS) is 6.91. Over the past 24 hours, the stock has changed by -2.26%. Follow the ALGS chart for real-time price dynamics.
What is the stock ticker of Aligos Therapeutics, Inc. Common Stock?
Aligos Therapeutics, Inc. Common Stock trades under the ticker ALGS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aligos Therapeutics, Inc. Common Stock stock going up?
ALGS has changed by +7.63% over the last week, +67.31% over the last month, and -29.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aligos Therapeutics, Inc. Common Stock?
Aligos Therapeutics, Inc. Common Stock currently has a market capitalization of 23.94 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Aligos Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Aligos Therapeutics, Inc. Common Stock reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aligos Therapeutics, Inc. Common Stock revenue for the last quarter?
Aligos Therapeutics, Inc. Common Stock reported quarterly revenue of 200 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aligos Therapeutics, Inc. Common Stock net income for the last quarter?
Aligos Therapeutics, Inc. Common Stock reported net income of -1.5 M for the last quarter. The previous quarter showed -23.04 M, which means net income changed by +93.47%.
How many employees does Aligos Therapeutics, Inc. Common Stock have?
As of the latest available data, Aligos Therapeutics, Inc. Common Stock has 82 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aligos Therapeutics, Inc. Common Stock EBITDA?
Aligos Therapeutics, Inc. Common Stock EBITDA is -29.24 M, and its EBITDA margin is -14.62 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aligos Therapeutics, Inc. Common Stock stock?
You can buy Aligos Therapeutics, Inc. Common Stock (ALGS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aligos Therapeutics, Inc. Common Stock stock?
Investing in Aligos Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALGS chart and related analysis on metatrader.com as part of your research.